Sun Pharma gets USFDA nod for eye inflammation drug
The company is likely to commercialise BromSite through its newly formed US-based division Sun Ophthalmics in the second half of 2016.
Apr 11, 2016, 08:23 AM IST
The company is likely to commercialise BromSite through its newly formed US-based division Sun Ophthalmics in the second half of 2016.
Apr 11, 2016, 08:23 AM IST